Novo Integrated Sciences Inc (NVOS) - Total Liabilities
Based on the latest financial reports, Novo Integrated Sciences Inc (NVOS) has total liabilities worth $17.53 Million USD as of November 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Novo Integrated Sciences Inc (NVOS) net asset momentum to track the company's year-over-year net asset growth rate.
Novo Integrated Sciences Inc - Total Liabilities Trend (2004–2024)
This chart illustrates how Novo Integrated Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. See Novo Integrated Sciences Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Novo Integrated Sciences Inc Competitors by Total Liabilities
The table below lists competitors of Novo Integrated Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TROUBADOUR RESOURCES INC.
F:2QD0
|
Germany | €325.75K |
|
Crimson Tide plc
LSE:TIDE
|
UK | GBX1.29 Million |
|
Walker Crips Group PLC
LSE:WCW
|
UK | GBX23.14 Million |
|
The Siam Cement Public Company Limited
F:TCM1
|
Germany | €424.75 Billion |
|
Marechale Capital Plc
LSE:MAC
|
UK | GBX123.20K |
|
Headlam Group
LSE:HEAD
|
UK | GBX244.70 Million |
|
Kasikornbank Public Company Limited
F:TFBF
|
Germany | €3.88 Trillion |
|
Empire Metals Limited
LSE:GEO
|
UK | GBX834.10K |
Liability Composition Analysis (2004–2024)
This chart breaks down Novo Integrated Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Novo Integrated Sciences Inc (NVOS) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Novo Integrated Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Novo Integrated Sciences Inc (2004–2024)
The table below shows the annual total liabilities of Novo Integrated Sciences Inc from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-08-31 | $17.53 Million | +58.42% |
| 2023-08-31 | $11.06 Million | -59.57% |
| 2022-08-31 | $27.36 Million | +50.74% |
| 2021-08-31 | $18.15 Million | +211.98% |
| 2020-08-31 | $5.82 Million | -13.53% |
| 2019-08-31 | $6.73 Million | +47.24% |
| 2018-08-31 | $4.57 Million | -53.38% |
| 2017-08-31 | $9.80 Million | -1.65% |
| 2016-09-30 | $9.97 Million | +75869.89% |
| 2016-08-31 | $13.12K | -97.98% |
| 2015-08-31 | $648.26K | -50.35% |
| 2014-08-31 | $1.31 Million | +56.94% |
| 2013-08-31 | $831.89K | -64.66% |
| 2012-08-31 | $2.35 Million | -12.14% |
| 2011-08-31 | $2.68 Million | +78.83% |
| 2010-08-31 | $1.50 Million | +2.68% |
| 2009-08-31 | $1.46 Million | +57.43% |
| 2008-08-31 | $926.74K | +185.61% |
| 2007-08-31 | $324.47K | -21.15% |
| 2006-08-31 | $411.53K | -1.56% |
| 2005-08-31 | $418.04K | 0.00% |
| 2004-08-31 | $418.04K | -- |
About Novo Integrated Sciences Inc
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, … Read more